Doxepin Hydrochloride
FDA Label NDC 70518-0386

15 label sections · Submitted to the FDA by Remedyrepack Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Remedyrepack Inc. for the product Doxepin Hydrochloride (NDC 70518-0386). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding suicidality and antidepressant drugs, description, clinical pharmacology, indications and usage, contraindications, warnings, information for patients, drug interactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.